견적문의

NEUCHATEL, SWITZERLAND--( / )--The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both using the Instant Focus EDOF patented technology. With a brand-new concept, LUCIDIS brings two major achievements for the monofocal market: extending the depth of focus on a monofocal lens while being the first affordable EDOF IOL. Thanks to its advanced refractive design, it allows an extension towards the near and intermediate vision. At the same time, SAV-IOL is building on the success of the InFo lens for the multifocal market: with a convenient blister packaging, EDEN, the reference in the premium hybrid segment, offers high performance continuous vision.

“Through EDEN, we consolidate our current product range with regards to high vision performance, based on our strong patients’ feedback. With LUCIDIS, the positioning is totally different: it’s a breakthrough product that provides an extended vision for patients at an affordable price. We are very excited to release LUCIDIS as the first EDOF monofocal lens.” says Max Boysset, CEO of Swiss Advanced Vision. “Offering Swiss made EDOF technology to the largest number of patients is our mission. SAV-IOL addresses now the mono- and multifocal markets with LUCIDIS and EDEN. Looking at the future, we are already working on a new product line made of IOLs that will fit individual patients need.”

LUCIDIS, EDEN, and InFo lenses, through the Instant Focus technology, are designed to provide patients suffering from cataract a high-quality solution to retrieve a continuous vision with minimized dysphotopsia while preserving the resolution and contrast sensitivity. All lenses are available with an external diameter of 10.8 mm and 12.4 mm, in a plastic blister packaging (EDEN and LUCIDIS) and in glass vial packaging (InFo).

About SAV-IOL SA: Swiss company located in the French speaking part of Switzerland. BSI site certification MD 615363

About LUCIDIS, EDEN, InFo: Intraocular lens +5.0 D to 30.0 D, by step of 0.5 D, available in 10.8 mm and 12.4 mm. BSI CE certification CE 615365

View source version on businesswire.com:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network

SUMMIT, N.J.--( / )--Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for 하늘하늘 SUMMIT,treatment of adult patients with oral ulcers 동영상성인 아바타얼굴합성 associated with Behcet’s Disease. OTEZLA, 동영상성인 이승기과다노출 단대동홀덤바 이승기과다노출 an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behcet’s Disease, a rare, chronic, multisystem inflammatory disease 동영상성인 that is difficult to treat.

“Oral ulcers are a recurring 동영상성인 경범죄처벌법개정안 and debilitating manifestation that affects nearly everyone living with Behcet’s 단대동홀덤바 낸시랭 Disease, and have an 단대동홀덤바 곽현화개그콘서트 important negative impact on the quality of life for these patients,” said Yusuf 동영상성인 곽현화바나나 Yazici, 단대동홀덤바 M.D., Clinical Associate Professor, Department of Medicine, New York 동영상성인 티아라지연버디버디동영상 University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA 일딸넷 “Oralthe potential to be a needed treatment option for U.S. patients and their physicians, who previously had limited options available.”

Behcet’s Disease, also known 동영상성인 광고사이트차단 as Behcet’s Syndrome, affects approximately 단대동홀덤바 김연아올림픽해외자막 5 in 100,000 people in the U.S.[1,2] Oral ulcers, the most common manifestation of 단대동홀덤바 맛집추천사이트 Behcet’s Disease occurring in more than 단대동홀덤바 김연아해외방송 98% of patients, can be painful, disabling and negatively affect quality of life.[3]

“We are excited to provide the first and only FDA-approved 동영상성인 treatment for oral ulcers associated with Behcet’s Disease,” said Terrie Curran, President, Celgene 단대동홀덤바 Inflammation & Immunology. “This approval is a reflection of Celgene’s commitment to research in areas of high unmet need, 단대동홀덤바 including rare diseases such as Behcet’s Disease. We remain dedicated to further studying OTEZLA and its role in inflammatory conditions.”

The FDA approval was 단대동홀덤바 박시후유출닷컴 based on efficacy and safety results from the randomized, placebo-controlled, double-blind Phase 3 RELIEF™ study evaluating OTEZLA in 207 adult patients with Behcet’s Disease with active oral ulcers who were previously treated with at least one nonbiologic medication and were candidates for systemic therapy. Results showed OTEZLA 30 mg BID resulted in a 42.7 point reduction from baseline in the pain of oral ulcers 동영상성인 축구동영상사이트 as measured by the visual analog scale (VAS) at week 12, compared with an 18.7 point reduction with placebo. The proportion of patients 동영상성인 유투브같은사이트 achieving an oral ulcer complete response (oral ulcer-free) at week 12 was 52.9% in the OTEZLA arm and 22.3% in the placebo arm. The 단대동홀덤바 proportion of patients achieving oral ulcer complete response by week 6 and who remained oral ulcer-free for at least six additional weeks during the 12-week treatment phase was 29.8% in the OTEZLA arm and 4.9% in the placebo arm. The daily average number of oral ulcers during the 12-week treatment phase was 1.5 in the OTEZLA arm and 2.6 in the placebo arm (based on oral ulcer counts measured at baseline and at weeks 1, 2, 4, 6, 8, 10 and 12).

“Behcet’s Disease is 동영상성인 왕뽕프릴비키니 a chronic inflammatory disease in which patients present with symptoms 이지유 “Behcet’sas oral ulcers that can have a significant impact on daily 단대동홀덤바 구하라성형전사진 life,” said Mirta Avila Santos, M.D., Executive Director, American Behcet’s Disease Association. “Today’s approval for OTEZLA marks an important milestone for people with Behcet’s Disease who have been 단대동홀덤바 eagerly waiting for treatment 동영상성인 구하라허리유이 options for their oral ulcers.”

The most common adverse events observed occurring in ≥10% of patients in the RELIEF trial were diarrhea 단대동홀덤바 구하라얼굴 (41.3% with OTEZLA; 20.4% 동영상성인 비키니라인제모가격 for placebo), nausea (19.2% with OTEZLA; 10.7% for placebo), headache 단대동홀덤바 비키니라인레이저제모 (14.4% with OTEZLA; 10.7% for placebo) and upper respiratory tract infection (11.5% with OTEZLA; 4.9% for placebo). The safety profile was consistent with the known safety profile of OTEZLA.

OTEZLA is now approved for three 동영상성인 indications in the U.S., including the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, adult patients with active psoriatic arthritis 단대동홀덤바 비치웨어원피스 and adult patients with oral ulcers 동영상성인 비키니라인왁싱 associated with Behcet’s Disease. Since its initial FDA approval in 2014, OTEZLA has been prescribed to more than 250,000 patients with moderate to severe plaque psoriasis or 야나무 OTEZLApsoriatic arthritis in the U.S.[4]

OTEZLA is 단대동홀덤바 available in the U.S. and 여자자위 OTEZLAdispensed through a comprehensive network 동영상성인 여성비치웨어 of 단대동홀덤바 A컵비키니쇼핑몰 specialty pharmacies. For more information about accessing OTEZLA and patient support services (including reimbursement assistance 단대동홀덤바 중국4대미녀 and 24/7 nurse support), doctors and patients can 동영상성인 큰컵비키니쇼핑몰 contact OTEZLA® SupportPlus™ at 1-844-4OTEZLA (1-844-468-3952) or visit for more information.

Celgene anticipates a regulatory 동영상성인 예쁜비키니쇼핑몰 decision for OTEZLA in oral ulcers associated with Behcet’s Disease from the 동영상성인 딸샤워 Pharmaceuticals and Medical Devices Agency in Japan in the second half of 2019. The Company also submitted 단대동홀덤바 몽선선데뷔 a Type II Variation 단대동홀덤바 최고노출 to the Marketing Authorization Application earlier this year seeking approval in 동영상성인 여자가싫어하는남자 the European Union.

About 동영상성인 여자들의흔한착각 누드여자 AboutRELIEF™ Study 단대동홀덤바 여자의마음은거짓말을한다

The RELIEF™ study is a Phase 3 randomized, placebo-controlled, double-blind study evaluating OTEZLA 단대동홀덤바 남자친구가좋아하는행동 30 mg BID in 207 adult patients with Behcet’s Disease with 단대동홀덤바 여자친구가좋아하는행동 active oral ulcers who were 동영상성인 바닐라민트지혜 previously treated with at least one nonbiologic medication and were candidates for systemic therapy. This 64-week study was conducted at 53 sites across 10 countries.

In the study, 207 adult patients were randomized 1:1 to receive either OTEZLA 30 동영상성인 유키몰 mg BID (n=104) or placebo (n=103) for the 12-week placebo-controlled treatment phase. Upon completion of week 12, all patients 단대동홀덤바 received OTEZLA for the 52-week active treatment phase. Efficacy was assessed based on the number and pain of oral ulcers, including the daily average number of oral ulcers during the 12-week placebo-controlled treatment phase.

섹스사이트 AboutBehcet’s 동영상성인 오감도노출 단대동홀덤바 오감도노출 Disease 동영상성인 갤럭시s2 단대동홀덤바 갤럭시s2

Behcet’s Disease is associated with abnormalities of the immune system and inflammation of the blood vessels. Behcet’s Disease is characterized by recurrent oral and genital ulcers, skin lesions, uveitis, arthritis, vascular, central nervous system and gastrointestinal 동영상성인 involvement. Oral ulcers are present in 단대동홀덤바 블로그로돈벌기 more than 98% of 단대동홀덤바 Behcet’s Disease patients.

Behcet’s Disease has been classified in the U.S. as a rare or “orphan” disease by the National Institutes of Health. At this time, there are 동영상성인 오감도노출 limited approved therapies to treat Behcet’s Disease in the U.S. Prevalence of Behcet’s 동영상성인 블로그검색등록방법 Disease 단대동홀덤바 한로그 is 단대동홀덤바 아이보스 highest in the Middle East, Asia and Japan.

About 동영상성인 파워씽씽 OTEZLA® 단대동홀덤바 (apremilast) 단대동홀덤바 한랭크

OTEZLA® (apremilast) 30 mg tablets is an oral small-molecule inhibitor of phosphodiesterase 4 (PDE4) specific for cyclic adenosine 동영상성인 겟몰 monophosphate (cAMP). PDE4 inhibition 단대동홀덤바 results in increased intracellular cAMP levels, which is thought to indirectly modulate the production of inflammatory mediators. The specific mechanism(s) by which OTEZLA exerts 단대동홀덤바 전단지 its therapeutic action in patients is 단대동홀덤바 여행블로그 not well defined.

U.S. 동영상성인 블로그홍보 단대동홀덤바 블로그홍보 PRESCRIBING 동영상성인 구글블로그 INFORMATION

섹스마스터 INDICATIONS동영상성인 단대동홀덤바

Otezla® (apremilast) is indicated for the treatment 동영상성인 블로그홍보비법 of patients with moderate to severe plaque psoriasis 단대동홀덤바 블로그홍보프로그램 who are 동영상성인 현아아이스크림mr제거 단대동홀덤바 현아아이스크림mr제거 candidates for 단대동홀덤바 네이버블로그검색등록 phototherapy or 비아그라등 Otezla®therapy.

Otezla is 단대동홀덤바 indicated for 단대동홀덤바 아이스크림브랜드 the treatment of 동영상성인 단대동홀덤바 adult patients 동영상성인 대학전문유학원 with active psoriatic arthritis. 동영상성인 경산세탁기청소

Otezla is indicated for the 동영상성인 아이스크림홈런 축구승무패39회차 Otezlaof adult 동영상성인 겟몰 patients with oral 단대동홀덤바 고두림아이스크림 ulcers associated with 단대동홀덤바 아이스크림12 Behcet’s Disease.

IMPORTANT SAFETY 동영상성인 네이버키워드광고 지옥넷새주소 IMPORTANT단대동홀덤바 i-scream

Contraindications 동영상성인 단대동홀덤바

Otezla® (apremilast) is 단대동홀덤바 contraindicated in patients with a known 동영상성인 hypersensitivity to apremilast or to any of the 쎅시팬티 Otezla®in the formulation

텀블러/인스타그램 Warningsand Precautions 동영상성인 현아흐트러지지마 단대동홀덤바 현아흐트러지지마

Diarrhea, Nausea and Vomiting: Cases of severe diarrhea, nausea, and vomiting 동영상성인 아이스크림안무 were associated with the use 단대동홀덤바 of Otezla. Most events occurred within the 동영상성인 블로그피아 first few weeks of treatment. In some cases 야한사람 Diarrhea,were hospitalized. Patients 65 years of age or older and patients taking medications that can lead to volume depletion or hypotension may be at a higher risk of complications from severe diarrhea, nausea, or vomiting. Monitor patients who are more susceptible to complications of diarrhea or vomiting; advise patients to contact their healthcare 동영상성인 아이스크림쇼핑몰 provider. Consider Otezla dose reduction or suspension if patients develop severe 단대동홀덤바 윤아다리수술 diarrhea, nausea, or vomiting

Depression: Carefully weigh the risks and benefits of treatment with Otezla for patients with a history of depression and/or suicidal thoughts/behavior, or in patients who develop such 동영상성인 symptoms while on Otezla. Patients, caregivers, and families should be advised of the need to be 동영상성인 박지성윤아 alert for 단대동홀덤바 the emergence or worsening of depression, suicidal thoughts or other 단대동홀덤바 서현허벅지 mood changes, and they should contact their healthcare provider if such changes occur

Psoriasis: Treatment with Otezla is associated with an increase in depression. During clinical trials, 1.3% (12/920) of patients reported depression compared to 0.4% (2/506) on placebo. 밤놀 Psoriasis:was reported as serious in 0.1% 단대동홀덤바 장근석 (1/1308) of patients exposed to Otezla, compared to none in placebo-treated patients (0/506). Suicidal behavior was observed 동영상성인 박민영소주광고 in 0.1% (1/1308) of patients on Otezla, compared to 0.2% (1/506) on placebo. One patient 단대동홀덤바 가인피어나듣기 treated with Otezla attempted suicide; 단대동홀덤바 참이슬광고 one patient on placebo committed suicide

Psoriatic Arthritis: 동영상성인 문채원노출 Treatment with 단대동홀덤바 나르샤성형전 Otezla is associated with an increase in depression. 매일티비 Psoriaticclinical trials, 1.0% (10/998) reported depression or depressed mood compared to 0.8% (4/495) treated with placebo. Suicidal ideation and behavior was observed in 0.2% 단대동홀덤바 (3/1441) of patients on Otezla, compared to none in placebo-treated patients. 단대동홀덤바 Depression was reported as serious in 0.2% (3/1441) of patients exposed to Otezla, compared to none in 동영상성인 제시카다리 placebo-treated patients (0/495). Two patients who received 동영상성인 가인생얼 placebo committed suicide compared to none on Otezla.

Behcet’s Disease: Treatment with Otezla is associated with an increase in depression. During the clinical trial, 1% (1/104) 동영상성인 장현승기습키스 reported depression or depressed mood compared to 1% (1/103) treated with placebo. No instances of suicidal ideation or behavior were reported in patients treated with Otezla or 단대동홀덤바 버블팝뮤비 treated 동영상성인 with placebo.

Weight Decrease: Monitor body 동영상성인 아이유노출사진 weight 동영상성인 regularly; 단대동홀덤바 씨스타나혼자뮤비 evaluate unexplained or clinically 동영상성인 엠카현아버블팝 significant 단대동홀덤바 현아체인지인기가요 weight loss, and consider discontinuation of Otezla 단대동홀덤바 윤아가슴성형에이스

Psoriasis: Body weight loss of 5-10% occurred 단대동홀덤바 트러블메이커mama in 12% (96/784) of patients treated with Otezla and in 5% (19/382) of patients 단대동홀덤바 treated with placebo. 동영상성인 윤아이민호 Body weight loss of ≥10% occurred in 2% (16/784) of 동영상성인 윤아키 patients treated with Otezla compared to 1% (3/382) 단대동홀덤바 버블팝안무거울모드느리게 of patients treated with placebo

Psoriatic 동영상성인 Arthritis: Body weight 동영상성인 버블팝안무거울모드 loss of 5-10% was reported 단대동홀덤바 현아버블팝뮤비 in 10% (49/497) of 단대동홀덤바 세바퀴현아체인지 patients 단대동홀덤바 taking Otezla and in 3.3% (16/495) of patients 동영상성인 가인피어나듣기 taking placebo.

Behcet’s Disease: Body weight loss 동영상성인 현아체인지뮤비 of >5% was reported in 4.9% 고추맛집 Behcet’sof 동영상성인 현아현승트러블메이커 patients 동영상성인 단대동홀덤바 taking Otezla and in 3.9% 단대동홀덤바 (4/102) of patients taking placebo.

Drug Interactions: Apremilast exposure 단대동홀덤바 was decreased 단대동홀덤바 레이디가가양성 when Otezla was co-administered 동영상성인 포미닛현아쩍벌춤 with rifampin, a strong CYP450 enzyme inducer; loss 단대동홀덤바 수지성희롱일베 of Otezla efficacy may 고추맛집 DrugConcomitant use of Otezla with CYP450 enzyme inducers (e.g., rifampin, phenobarbital, carbamazepine, phenytoin) is not recommended

Adverse 동영상성인 가인팅커벨 Reactions 단대동홀덤바 가인피어나19

Psoriasis: Adverse 단대동홀덤바 reactions 동영상성인 reported in ≥5% of 고추맛집 Psoriasis:were (Otezla%, placebo%): diarrhea (17, 6), 동영상성인 수지브라더비 nausea (17, 7), upper 단대동홀덤바 가인미니홈피 respiratory tract infection (9, 단대동홀덤바 가인비키니사진 6), tension headache (8, 4), and headache (6, 4)

Psoriatic Arthritis: 단대동홀덤바 나르샤비키니 Adverse reactions reported in at least 2% of patients taking Otezla, 동영상성인 손가인 that occurred at a frequency at least 1% higher than that observed in patients taking placebo, for up to 16 weeks 동영상성인 맥심잡지파는곳 (after the initial 5-day titration), were (Otezla%, placebo%): diarrhea (7.7, 1.6); nausea 단대동홀덤바 (8.9, 3.1); headache (5.9, 2.2); 단대동홀덤바 현아화장실셀카 upper respiratory tract infection (3.9, 1.8); vomiting (3.2, 0.4); nasopharyngitis (2.6, 1.6); 성인섹스 Psoriaticabdominal pain (2.0, 0.2)

Behcet’s Disease: Adverse reactions reported in at least ≥5% of patients taking Otezla, that occurred at a frequency at least 1% higher than 동영상성인 코스프레애니멀 that observed in patients taking placebo, for up 단대동홀덤바 쿨댄스 to 12 weeks were (Otezla%, placebo%): diarrhea (41.3, 20.4); nausea (19.2, 10.7); headache (14.4, 10.7); upper respiratory tract infection (11.5, 단대동홀덤바 이세연 4.9); upper abdominal pain (8.7, 1.9), vomiting 동영상성인 (8.7, 1.9); back pain (7.7, 5.8); viral upper respiratory tract infection (6.7, 4.9); arthralgia (5.8, 2.9).

Use in 동영상성인 테니스선수노출 자브서울 Use동영상성인 현아버블팝뮤직뱅크 Populations 단대동홀덤바

Pregnancy: Otezla has not been studied in pregnant women. Advise pregnant 단대동홀덤바 현아버블팝mr제거 women of the potential risk of fetal loss. Consider pregnancy planning and prevention for females of 동영상성인 reproductive potential. There is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to Otezla during pregnancy. Information about the registry can be obtained by calling 1-877-311-8972 or visiting

Lactation: 동영상성인 There are no data on the presence of apremilast or its metabolites in human milk, 단대동홀덤바 현아자동차cf the effects of apremilast on the breastfed infant, or the effects of the drug on milk production. The developmental and health benefits of breastfeeding should be considered 삐콤 Lactation:with the mother’s clinical need for Otezla and any potential 동영상성인 adverse effects on the breastfed child from Otezla or from the underlying maternal condition. 단대동홀덤바 영화김종욱찾기

Renal Impairment: Otezla dosage should be reduced in patients 동영상성인 현아아이스크림움짤 with severe renal impairment (creatinine clearance less than 30 mL/min); for details, see Dosage and Administration, 비닉스 Renal2, in 단대동홀덤바 홍어산란기 the Full 단대동홀덤바 아이유성희롱 Prescribing Information.

Please click here () 여성세정제파는곳 Please동영상성인 무한공유맥스 단대동홀덤바 무한공유맥스 Full Prescribing Information.

About 가평읍하드코어 About동영상성인 토렌트무한공유 단대동홀덤바 토렌트무한공유

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated 동영상성인 global pharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer 동영상성인 윈도우7드라이브공유 and inflammatory diseases through next?generation solutions in 단대동홀덤바 protein homeostasis, immuno?oncology, epigenetics, immunology and neuro?inflammation. For more information, please visit Follow Celgene 동영상성인 씬시티 on Social Media: @Celgene, Pinterest, LinkedIn, Facebook and YouTube.

손담비트랜스젠더 Forward-Looking동영상성인 네오폴더 단대동홀덤바 네오폴더 Statements 단대동홀덤바 셔터아일랜드

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management's current plans, estimates, assumptions and projections, and 단대동홀덤바 컴퓨터공유하기 speak only as of the date they are made. We undertake no obligation 동영상성인 편지지프린트 to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks 동영상성인 비스타네트워크공유 and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact 동영상성인 일반인쩌는 of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the 단대동홀덤바 던파코스프레 U.S. Securities and Exchange Commission, including factors related to the proposed transaction between Bristol-Myers Squibb and Celgene, such as, but not limited to, the risks that: management’s time and attention is diverted on transaction related issues; disruption from the transaction make it more difficult to maintain business, contractual and operational relationships; legal proceedings are instituted against Bristol-Myers Squibb, 단대동홀덤바 Celgene or the combined company that could delay or prevent the proposed transaction; and Bristol-Myers Squibb, Celgene or the combined company is unable to retain key personnel.

Hyperlinks are provided as a convenience and 단대동홀덤바 유황우 for informational purposes only. 단대동홀덤바 Celgene bears 적선동성인인형체험 Hyperlinks동영상성인 소셜네트워크 responsibility 동영상성인 샤라포바호날두 for the security 동영상성인 피카사 or content of external websites.

All 동영상성인 윤아허리돌리기 trademarks are the 동영상성인 전효성허리돌리기 property 케이섹스 All단대동홀덤바 유이허리돌리기 their respective 동영상성인 샤라포바민망사진 owners.

[1] Zeidan MJ, Saadoun D, Garrido 동영상성인 허리테크닉 M , 단대동홀덤바 김혜수노출영화 Klatzmann D, Six A, Cacoub P. 셀트리온주식 [1]disease physiopathology: a contemporary review. Autoimmun Highlights. 2016;7(1):4. 동영상성인 김태희유아인

tYkws [2]Leonardo NM, McNeil 동영상성인 김태희공부비법 J. 단대동홀덤바 김태희비데이트사진 Behcet’s disease: is 동영상성인 김태희 there geographical variation? A review far from the Silk Road. Int J Rheumatol. 2015;2015:945262.

[3] 동영상성인 강지영엉덩이 Medscape 동영상성인 김태희아프리카사건 EMedicine. Dermatological Aspects of Behcet Disease Clinical Presentation. Accessed 단대동홀덤바 강지영움짤 February 2019.

[4] 동영상성인 박규리 Symphony 동영상성인 미스에이노출 Health Solution PrescriberSource PatientFocus, Includes 단대동홀덤바 all 단대동홀덤바 구하라성형전 prescriptions 단대동홀덤바 from 동영상성인 산다라박노출 April 2014 through April 2019.

View source version on businesswire.com:Korea 동영상성인 구하라용준형 Newswire 단대동홀덤바 distributes your news across every media channels through the industry’s largest press release distribution network